TSE:CXR Concordia International (CXR) Stock Price, News & Analysis Add Compare Share Share Today's Range N/A50-Day RangeC$25.04▼C$25.0452-Week Range N/AVolume73,541 shsAverage Volume4,054 shsMarket CapitalizationC$1.22 billionP/E Ratio0.07Dividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Concordia International alerts: Email Address Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About Concordia International Stock (TSE:CXR)Concordia International Corp., a specialty pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products. The company operates through two segments, Concordia International and Concordia North America. The Concordia International segment owns or licenses a portfolio of branded and generic prescription products to wholesalers, hospitals, and pharmacies. This segment's products include Macrobid/Macrodantin to treat bladder infections, such as cystitis and urinary tract infections; Tetroxin drug for severe hypothyroid states; Eltroxin, levothyroxine sodium that treats patients with an underactive thyroid gland; and Fucithalmic, a topical gel treatment for patients suffering with a bacterial infection of the surface lining of the front of the eye. The Concordia North America segment provides Donnatalm, which is used as adjunctive therapy for irritable bowel syndrome; Zonegran, an anti-seizure drug indicated for adjunctive therapy in the treatment of partial seizures in adults with epilepsy; and Plaquenil and Plaquenil AG to treat rheumatoid arthritis and manage the complications of lupus, as well as suppress acute attacks from certain strains of malaria. This segment also offers photodynamic therapy with Photofrin for the treatment of certain forms of cancer that combines a photosensitizing agent with a specific type of laser that emits an exact wavelength of light and power to target cancer cells. The company sells its products through direct sales and local partnerships. The company was formerly known as Concordia Healthcare Corp. and changed its name to Concordia International Corp. in 2016. Concordia International Corp. is headquartered in Oakville, Canada.Read More Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here CXR Stock News HeadlinesMay 27, 2024 | msn.comConcordia cutting budget by $36M as it subsidizes French universities, Carr saysApril 26, 2024 | msn.comConcordia-Moorhead Announces $2.8 Million Track & Turf ProjectJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.March 27, 2024 | msn.comConcordia Studio Announces Filmmaker Fellows For 2024November 4, 2023 | msn.comOver a hundred local high school students visit Concordia College for entrepreneurship seminarOctober 24, 2023 | msn.comConcordia says Quebec's tuition plan will cost it 'tens of millions of dollars'May 17, 2023 | sports.yahoo.comConcordia Studio Selects Its 2023 Fellowship ClassApril 23, 2023 | fool.caWhy Concordia International Corp. Has Fallen +28% IntradayJuly 26, 2024 | DTI (Ad)How a $0.25 cent option contract makes my top traders feelIf you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…March 17, 2023 | news.yahoo.comConcordia University Wisconsin closed its Appleton, Madison and Milwaukee centers. Here's why.January 17, 2023 | msn.comAugustana provost named president of Concordia College in MinnesotaOctober 8, 2022 | msn.comHomestead girls, Concordia boys clinch cross country sectional titlesSeptember 9, 2022 | msn.comNo. 11 Concordia Prep football holds No. 3 McDonogh scoreless in second half in 26-7 upsetAugust 8, 2022 | msn.comColfax man arrested for sending explicit photos to Concordia minorJune 8, 2022 | msn.comDenham Springs man accused of asking Concordia minor for lewd photos, videosMay 21, 2022 | msn.comConcordia University Is Now Offering A Course On Kendrick LamarOctober 27, 2021 | finance.yahoo.comMorning News Call - Canada, March 15See More Headlines Receive CXR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Concordia International and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Biotechnology Sub-IndustryTransportation Current SymbolTSE:CXR CUSIPN/A CIKN/A Webconcordiarx.com Phone+1-905-8425150FaxN/AEmployees22,500Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio0.07 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio457.02 Current Ratio2.10 Quick Ratio1.66 Sales & Book Value Annual SalesC$569.62 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow5.85 Book ValueC$6.08 per share Price / BookN/AMiscellaneous Outstanding Shares48,913,000Free FloatN/AMarket CapC$1.22 billion OptionableNot Optionable BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Graeme Neville Duncan (Age 44)CEO & Director Mr. Karl Ian BelkChief Operations OfficerMr. Adeel Ahmad (Age 44)Chief Financial Officer Mr. Adam PeelerVP of Investor Relations & CommunicationsMr. Robert SullyGen. CounselKey CompetitorsHorizons Gold Producer Equity Covered Call ETFTSE:HEPClean Seed Capital GroupCVE:CSXLode Gold ResourcesCVE:SBPacton GoldCVE:PAC2323 (ANS.TO)TSE:ANSView All Competitors CXR Stock Analysis - Frequently Asked Questions How do I buy shares of Concordia International? Shares of CXR stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of Concordia International own? Based on aggregate information from My MarketBeat watchlists, some other companies that Concordia International investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET) and (CXRX) (CXRX). This page (TSE:CXR) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Concordia International Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Concordia International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.